The University of Chicago Header Logo

Connection

Radhika R. Peddinti to Osteonectin

Back to Details
This is a "connection" page, showing publications Radhika R. Peddinti has written about Osteonectin.
Radhika R. Peddinti
Connection Strength
0.160
Osteonectin
  1. Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors. Mol Cancer. 2010 Jun 04; 9:138.
    View in: PubMed
    Score: 0.089
  2. SPARC enhances tumor stroma formation and prevents fibroblast activation. Oncogene. 2007 Jul 05; 26(31):4513-22.
    View in: PubMed
    Score: 0.071
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.